Literature DB >> 11955852

Electrogram polarity reversal as an additional indicator of breakthroughs from the left atrium to the pulmonary veins.

Teiichi Yamane1, Dipen C Shah, Pierre Jaïs, Mélèze Hocini M, Isabel Deisenhofer, Kee-Joon Choi, Laurent Macle, Jacques Clémenty, Michel Haïssaguerre.   

Abstract

OBJECTIVES: We assessed the anatomical distribution and electrogram characteristics of breakthrough from the left atrium (LA) to the pulmonary veins (PVs).
BACKGROUND: Localization of LA-PV breakthrough is an important technique for PV ablation in patients with atrial fibrillation (AF).
METHODS: A total of 157 patients with paroxysmal AF underwent PV disconnection guided by mapping with a circumferential 10-electrode catheter. Radiofrequency (RF) current was delivered ostially at the site(s) of earliest activation (113 patients) or electrogram polarity reversal defined by opposite polarity across adjacent bipoles (44 patients). Breakthrough sites were proved by changes in pulmonary vein potential activation sequence occurring as a result of localized RF delivery and were classified into four segments around the ostium (top, bottom, anterior, posterior). Results of mapping and ablation were compared between the two groups.
RESULTS: A total of 99% of 411 targeted PVs were successfully disconnected in both groups. Breakthroughs were most frequent at the bottom of superior PVs (85% prevalence) and the top of inferior PVs (75% prevalence). A wide activation front (>5 synchronous bipoles) indicating broad breakthrough was observed in 18% of PVs. Polarity reversal occurred with 88% sensitivity and 91% specificity at breakthrough sites. Polarity reversal was restricted to fewer bipoles (2.0 +/- 0.4 bipoles vs. 3.4 +/- 2.0 bipoles, p < 0.01) compared with earliest activation. Shorter RF application time was required to disconnect PVs with wide synchronous activation using polarity reversal compared with using conventional earliest activity (10.3 +/- 3.0 min vs. 12.3 +/- 3.4 min, p < 0.05).
CONCLUSIONS: Bipolar electrogram polarity reversal allows more precise localization of breakthrough compared with the earliest activation, particularly in cases of wide synchronous PV activation.

Entities:  

Mesh:

Year:  2002        PMID: 11955852     DOI: 10.1016/s0735-1097(02)01782-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  6 in total

1.  Pace mapping in the atrium using bipolar electrograms from widely spaced electrodes.

Authors:  Raja J Selvaraj; Sreekanth Yerram; Pradeep Kumar; Santhosh Satheesh; Ajith Ananthakrishna Pillai; Mahesh Kumar Saktheeswaran; Jayaraman Balachander
Journal:  J Arrhythm       Date:  2015-03-20

2.  Plasma brain natriuretic peptide concentrations in patients undergoing pulmonary vein isolation.

Authors:  T Date; T Yamane; K Inada; S Matsuo; S Miyanaga; K Sugimoto; K Shibayama; I Taniguchi; S Mochizuki
Journal:  Heart       Date:  2006-06-01       Impact factor: 5.994

3.  Introduction of an expert system for the discrimination of local pulmonary vein and atrial far field signals.

Authors:  Hanno Ulrich Klemm; Thomas Heitzer; Ute Ruprecht; Christin Johnsen; Thomas Meinertz; Rodolfo Ventura
Journal:  J Interv Card Electrophysiol       Date:  2010-08-28       Impact factor: 1.900

Review 4.  Atrial fibrillation: what are the targets for intervention?

Authors:  John M Miller; Jeffrey E Olgin; Mithilesh K Das
Journal:  J Interv Card Electrophysiol       Date:  2003-10       Impact factor: 1.900

5.  The utility of atrial pacing for identifying the electrical breakthrough sites between the left atrium and pulmonary veins.

Authors:  Shinya Sugiura; Koji Matsuoka; Hideki Noda; Naoya Kurata; Misa Uemori; Hirokazu Shioji; Akihiro Takasaki; Takafumi Koji; Takashi Tanigawa; Masaaki Ito
Journal:  J Arrhythm       Date:  2016-09-19

Review 6.  Identifying Atrial Fibrillation Mechanisms for Personalized Medicine.

Authors:  Brototo Deb; Prasanth Ganesan; Ruibin Feng; Sanjiv M Narayan
Journal:  J Clin Med       Date:  2021-12-01       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.